Plain-English translation of NCT05133804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications — and (Ritalin) — given together can help people with PTSD feel better. Researchers believe that problems with attention and sensory processing may be connected to PTSD symptoms like flashbacks, avoidance, and being on high alert. This study wants to see if treating these attention and sensory problems can reduce overall PTSD symptoms.
Many people with PTSD don't fully recover with current treatments, and their symptoms stay serious and get in the way of daily life. Recent research suggests that difficulty concentrating and processing sensory information may be important parts of PTSD that aren't being treated well. This medication combination focuses on these overlooked areas to see if it can help more people recover.
You likely qualify if…
You likely don't qualify if…
You will first complete baseline tests to measure your attention, sensory processing, brain activity, and PTSD symptoms. Then you'll be randomly assigned to receive either the active medication combination or a placebo (inactive pill). You'll take for 3 weeks, then add for the final week, while researchers monitor you with brain scans, questionnaires, and symptom assessments. The study lasts about 4 weeks total.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Israel